English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

The Toxoplasma gondii number was evaluated by quantitative competitive polymerase chain reaction (QC-PCR) assay with or without sulfamethoxazole treatment in the heart, blood, brain, and small intestine of IFN-γ knockout (GKO) BALB/c (B/c) mice after peroral infection with the cyst-forming Fukaya strain. T. gondii infection was observed in the heart, blood, and brain, but not in the small intestine, of mice treated with sulfamethoxazole for 4 weeks. No correlation between T. gondii loads and sulfamethoxazole concentrations in tissues and blood was observed. T gondii was not detected in the heart and blood after continuous sulfamethoxazole treatment for two months, but a small number of parasites was demonstrated in the brain. Thus, we successfully established an animal model for evaluating chemotherapy regimens in immunocompromised hosts by using GKO B/c mice infected with T. gondii.

AN ANIMAL MODEL FOR ESTABLISHING CHEMOTHERAPY AGAINST INTRACTABLE TOXOPLASMOSIS IN IMMUNOCOMPROMISED HOSTS BY THE USE OF IFN-.GAMMA. KNOCKOUT MICE.